CALIXAR team will be present at the online i-GPCRnet from November 30th to December 03rd, 2021 to discuss different topics relating to Membrane Proteins and more specifically on GPCRs.G protein-coupled receptors (GPCRs) are among the most important protein families in sensing environmental changes at the cellular level providing them adequate response and adaptation. Their potential as drug targets has been recognized with 30-40% of currently marketed drugs targeting GPCRs.CALIXAR is a biotech company specialized in the identification and isolation of functional membrane therapeutic targets and antigens (GPCRs, ion channels, transporters, …) and is constantly improving to deliver the most pure and stable targets to biotechnology and pharmaceutical companies.During the session “Up and coming technologies to targets GPCRs”, Dr. Vincent CORVEST, Senior Scientist and Business Manager at CALIXAR will give a flash presentation on the know-how of CALIXAR on Membrane Proteins and works conducted on GPCRs.About i-GPCRnet:The ambition of the i-GPCRnet is to tackle the largely unexplored question of the impact of the microenvironments on GPCR function and how perturbation of this microenvironment impacts on common diseases such as cancer, metabolic and neurodegenerative diseases as well as their therapies. A better understanding of the GPCR microenvironment holds the promise of unprecedented therapeutic opportunities in terms of tissue specificity and specific pharmacological targeting that will eventually lead to the design of innovative and tailored drugs for precision medicine.To reach this goal the i-GPCRnet consortium will bring together chemists, biophysicists, bioinformaticians, mathematicians, systems and cellular biologists and pharmacologists.For more information and meet us: i-GPCRnet
